{
    "title": "Merck's Keytruda gets FDA nod for expanded use in lung cancer",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12637995/Mercks-Keytruda-gets-U-S-FDAs-nod-expanded-use-lung-cancer.html",
    "date": "2023-10-16",
    "keywords": [
        "use",
        "treatment",
        "drug",
        "cancer",
        "keytruda",
        "surgery",
        "merck",
        "lung",
        "chemotherapy",
        "followup",
        "survival",
        "disease",
        "earlystage",
        "approval",
        "combination",
        "latestage",
        "study",
        "setting",
        "analyst",
        "conover",
        "adult",
        "food",
        "administration",
        "monday",
        "amp",
        "cos",
        "blockbuster",
        "immunotherapy",
        "cell",
        "health",
        "size",
        "tumor",
        "decision",
        "drugmaker",
        "line",
        "end",
        "decade",
        "application",
        "agency",
        "trial",
        "primary",
        "period",
        "time",
        "patient",
        "product",
        "bodys",
        "immune",
        "system",
        "protein",
        "opportunity",
        "ellie",
        "davenport",
        "damien",
        "earlyline",
        "tecentriq",
        "plc",
        "imfinzi",
        "earlierline",
        "efficacy",
        "nsclc",
        "goal",
        "case",
        "population",
        "keytrudachemotherapy",
        "day",
        "commission",
        "risk",
        "resection",
        "reporting",
        "tanna",
        "pratik",
        "jain",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}